07 Jan 2001

SUBUTEX 0,4 (SUBUTEX 0,4 mg/-2 mg/-8 mg Sublingualtabletten) - Deutschland

Updated: 07 Jan 2001

SUBUTEX 0,4 mg | -2 mg | -8 mg

Substitutionstherapie bei Opioidabhängigkeit im Rahmen medizinischer, sozialer u. psychotherapeutischer Maßnahmen. Insbes. für die erste Substitutionstherapie von Opioid-Abhängigen mit kürzerer Dauer der Suchterkrankung u. weniger verfestigten Suchterkrankungen. Zur Beh. von Erw. über 18 J. die einer Suchtbehandl. zugestimmt haben.

SUBUTEX 0,4 Description, Presentation and Dosage

SUBUTEX 0,4 Description

SUBUTEX 0,4 Drug Class Description

Einzelstoffe

SUBUTEX 0,4 Drug Description

1 Sublingualtbl. enth.: Buprenorphin-HCl 0,432 mg/2,16 mg/8,64 mg (entspr. 0,4 mg/2 mg/8 mg Buprenorphin).

SUBUTEX 0,4 Generic Name

SUBUTEX 0,4 mg/-2 mg/-8 mg Sublingualtabletten

SUBUTEX 0,4 Presentation

SUBUTEX 0,4 Presentation

SUBUTEX 0,4 mg/-2 mg/-8 mg

SUBUTEX 0,4 Manufacturer

Essex Pharma

Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

SUBUTEX 0,4 Dosage

SUBUTEX 0,4 Adult Dosage

Lactose 1H2O, Mannitol, Maisstärke, Povidon K 30, Citronensäure, Natriumcitrat, Magnesiumstearat.

SUBUTEX 0,4 Precautions, Reactions and Contraindications

SUBUTEX 0,4 Special Precautions

SUBUTEX 0,4 Special Precautions

Schwere respiratorische Insuffizienz, schwere Leberinsuffizienz, akuter Alkoholismus od. Delirium tremens, Behandl. mit Monoaminooxidasehemmern. Kdr. u. Jugendl. unter 18 J. (keine Erkenntnisse zu Wirksamkeit u. Unbedenklichkeit).

SUBUTEX 0,4 Adverse Reactions

SUBUTEX 0,4 Adverse Reactions

A 85 b, c

Related Drugs - Pain Management

Back to top